Diagnostics chain Dr Lal PathLabs on Monday reported a 31.2 per cent decline in its consolidated net profit to Rs 32.6 crore for the quarter ended on March 31, 2020.
The companyhad posted a net profit of Rs 47.4 crore for the corresponding period of previous fiscal, Dr Lal PathLabs said in a BSE filing.
Consolidated revenue from operations stood at Rs301.7 crore for the quarter under consideration as against Rs301.1crore in the same period year ago, it added.
We are in an unprecedented and difficult times. These times are not only impacting the current financial year but impacted Q4FY20 results as well not just for Dr Lal Pathlabs, but for the entire nation and the economy. Business was impacted adversely, with volumes getting hit,"Dr Lal PathLabs Executive Chairman Arvind Lal said.
For the full year 2019-20, the company posted a net profit of Rs 227.6 crore. It was Rs 200.5 crore in the year-ago period, the filing said.
Consolidated revenue from operations stood at Rs 1,330.4 crore for the fiscal ended March this year. It was Rs 1,203.4 crore in 2018-19.
Shares of Dr Lal PathLabs closed at Rs1,583.35per scrip on the BSE, down 0.78 per cent over previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app